Randomised, Double-blind, Parallel-group, Placebo-controlled Study of Lu AE58054 in Patients With Mild to Moderate Alzheimer's Disease Treated With an Acetylcholinesterase Inhibitor
Phase of Trial: Phase III
Latest Information Update: 06 Jun 2017
At a glance
- Drugs Idalopirdine (Primary)
- Indications Alzheimer's disease
- Focus Registrational; Therapeutic Use
- Acronyms STARBRIGHT
- Sponsors Lundbeck A/S
- 13 Jan 2017 Status changed from active, no longer recruiting to completed.
- 22 Sep 2016 According to a Lundbeck media release, results of this trial are anticipated in the first quarter of 2017.
- 14 Jul 2016 Status changed from recruiting to active, no longer recruiting.